HUTCHMED (China) Ltd

Common Name

HUTCHMED (China)

Country

Hong Kong

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1,780

Ticker

Exchange

HONG KONG EXCHANGES AND CLEARING LTD

Website

www.hutch-med.com

Description

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the... Show more

Financial Statements of HUTCHMED (China)

Below are the financial statements of HUTCHMED (China), including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023	2022
Revenue	—	—	—
Goods - third parties	401.38^a	388.92^a	314.33^a
Goods - related parties	3.85^a	8.26^a	5.29^a
Services - commercialization - third parties	52.49^a	48.61^a	41.28^a
Services - research and development - related parties	0.47^a	0.48^a	0.51^a
Services - collaboration research and development - third parties	57.97^a	80.4^a	23.74^a
Other collaboration revenue - royalties - third parties	71.04^a	32.47^a	26.31^a
Other collaboration revenue - licensing - third parties	43^a	278.86^a	14.95^a
Total revenue	630.2^a	838^a	426.41^a
Operating expenses	—	—	—
Cost of goods - third parties	-294.92^a	-331.98^a	-268.7^a
Cost of goods - related parties	-1.86^a	-4.78^a	-3.62^a
Cost of services - commercialization - third parties	-52.11^a	-47.69^a	-38.79^a
Research and development expenses	-212.11^a	-302^a	-386.89^a
Selling expenses	-48.62^a	-53.39^a	-43.93^a
Administrative expenses	-64.3^a	-79.78^a	-92.17^a
Total operating expenses	-673.91^a	-819.62^a	-834.1^a
Other income/(expense)	—	—	—
Interest income	40.08^a	36.15^a	9.6^a
Other income	10.27^a	12.95^a	1.83^a
Interest expense	-2.87^a	-0.76^a	-0.65^a
Other expense	-4.88^a	-8.4^a	-13.51^a
Total other income/(expense)	42.6^a	39.93^a	-2.73^a
(Loss)/income before income taxes and equity in earnings of an equity investee	-1.11^a	58.31^a	-410.42^a
Income tax (expense)/benefit	-7.19^a	-4.51^a	0.28^a
Equity in earnings of an equity investee, net of tax	46.47^a	47.3^a	49.75^a
Net income/(loss)	38.17^a	101.09^a	-360.39^a
Less: Net income attributable to non-controlling interests	-0.44^a	-0.31^a	-0.45^a
Net income/(loss) attributable to the company	37.73^a	100.78^a	-360.84^a

Download Data

Verified Sources Behind HUTCHMED (China)’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore HUTCHMED (China)’s data sources below and access millions more through our Disclosure Search.

a. HUTCHMED (China)'s Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

HUTCHMED (China) Ltd

Financial Statements of HUTCHMED (China)

Verified Sources Behind HUTCHMED (China)’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

China Resources Pharmaceutical Group Ltd

Gland Pharma Ltd

Alkem Laboratories Ltd

Tasly Pharmaceutical Group Co Ltd

IPCA Laboratories Ltd

Glenmark Pharmaceuticals Ltd